American depository receipts of European stocks were 0.7% higher at 137.55 on the Bank of New York Mellon Europe ADR Index on Monday morning.
Gainers in Continental Europe were led by Oasmia Pharmaceutical ( OASM ), a Sweden-based pharmaceutical company, 14.6% higher, followed by Banco Santander ( SAN ), 3% higher and Logitech ( LOGI ), a Swiss hardware and software products developer, up by 2.9%. Materialise ( MTLS ), a Belgian provider of 3D printing software and services, was 2.7% higher.
In the UK, Akari Therapeutics ( AKTX ), a development-stage biopharmaceutical company, was 12.5% higher, Carnival (CUK), a cruise vacation company, was up by 2.9%, Astrazeneca (AZN), a biopharmaceutical company, was 1.7% higher and Amarin (AMRN), a biopharmaceutical company, was up by 1.6%.
Decliners in Continental Europe were led by Sanofi (SNY), a French healthcare company, down by 1.6%, Ascendis Pharma (ASND), a Danish clinical stage biopharmaceutical company, 1.4% lower, Edap (EDAP), a French medical devices developer, down by 1.3% and Cellectis (CLLS), a French genome engineering company, 1.3% lower.
And, in the UK, Randgold Resources (GOLD), a gold-mining company, was 1.4% lower, Adaptimmune Therapeutics (ADAP), a clinical-stage biopharmaceutical company, was down by 1.0% and Royal Bank of Scotland (RBS) was down by 0.3%. Lloyds Banking Group (LYG) was down by 0.3%.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.